Seropositivity for TPO, but not for Tg, was linked to breast cancer prevalence, while no correlation was identified between the presence of anti-thyroid antibodies and tumor estrogen and progesterone receptor status (158, 159). The gene discussed is TG; the disease is breast carcinoma.